Researchers compared the health outcomes of adult patients with moderate ulcerative colitis and early advanced therapy initiation with those who delayed their advanced treatment initiation.
The FDA approved resmetirom for the treatment of adults with metabolic dysfunction-associated steatohepatitis with moderate-to-advanced liver fibrosis.
Researchers compared the rates of elective vs emergency surgery for patients living in primary care shortage areas who had one of three access-sensitive surgical conditions.
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
Researchers with the American Gastroenterological Association (AGA) release a comprehensive set of guidelines on the use of biomarkers for monitoring and managing Crohn disease in patients.
The American College of Physicians have released an updated set of guidelines addressing when and how clinicians should screen for colorectal cancer in patients.
After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.
The American Gastroenterological Association (AGA) released a set of guidelines that outlines the use of biomarkers to treat and monitor ulcerative colitis in patients.
